-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of current income tax expense (benefit) pertaining to taxable income (loss) from continuing operations.
-
Summary
-
Atea Pharmaceuticals, Inc. quarterly/annual Current Income Tax Expense (Benefit) history and growth rate from Q2 2020 to Q3 2022.
- Atea Pharmaceuticals, Inc. Current Income Tax Expense (Benefit) for the quarter ending September 30, 2022 was -$3.83M.
- Atea Pharmaceuticals, Inc. annual Current Income Tax Expense (Benefit) for 2021 was $17.4K.
- Atea Pharmaceuticals, Inc. annual Current Income Tax Expense (Benefit) for 2020 was $0.000.
- Atea Pharmaceuticals, Inc. annual Current Income Tax Expense (Benefit) for 2019 was $0.000.
Current Income Tax Expense (Benefit), Quarterly (USD)
Current Income Tax Expense (Benefit), YoY Quarterly Growth (%)